Free Trial

Teacher Retirement System of Texas Buys 4,790 Shares of HealthEquity, Inc. (NASDAQ:HQY)

HealthEquity logo with Medical background

Teacher Retirement System of Texas boosted its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 25.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,829 shares of the company's stock after buying an additional 4,790 shares during the period. Teacher Retirement System of Texas' holdings in HealthEquity were worth $2,106,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of HQY. Versant Capital Management Inc bought a new stake in HealthEquity in the first quarter valued at approximately $28,000. Transce3nd LLC bought a new stake in HealthEquity in the fourth quarter valued at approximately $29,000. Proficio Capital Partners LLC bought a new stake in HealthEquity in the fourth quarter valued at approximately $39,000. Skandinaviska Enskilda Banken AB publ increased its stake in HealthEquity by 1,934.8% in the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock valued at $45,000 after purchasing an additional 445 shares in the last quarter. Finally, Whipplewood Advisors LLC increased its position in shares of HealthEquity by 5,060.0% during the first quarter. Whipplewood Advisors LLC now owns 774 shares of the company's stock worth $68,000 after acquiring an additional 759 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on HQY shares. Royal Bank Of Canada increased their price objective on shares of HealthEquity from $112.00 to $117.00 and gave the stock an "outperform" rating in a research report on Wednesday, June 4th. KeyCorp lowered their price objective on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a research report on Thursday, June 5th. Bank of America increased their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a research report on Wednesday, June 4th. Finally, JMP Securities increased their price objective on shares of HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a research report on Wednesday, June 4th. One investment analyst has rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, HealthEquity currently has a consensus rating of "Buy" and an average price target of $118.55.

Get Our Latest Stock Analysis on HealthEquity

HealthEquity Stock Up 3.0%

HealthEquity stock traded up $2.82 during mid-day trading on Monday, reaching $97.34. The company's stock had a trading volume of 1,294,364 shares, compared to its average volume of 870,664. The company has a market capitalization of $8.42 billion, a price-to-earnings ratio of 71.05, a price-to-earnings-growth ratio of 1.46 and a beta of 0.49. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $116.65. The business's 50 day simple moving average is $100.98 and its 200 day simple moving average is $98.44. The company has a debt-to-equity ratio of 0.50, a quick ratio of 4.06 and a current ratio of 4.06.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. The business had revenue of $330.80 million during the quarter, compared to the consensus estimate of $322.25 million. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. During the same quarter last year, the firm earned $0.80 earnings per share. As a group, research analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Jon Kessler sold 97,767 shares of the stock in a transaction on Friday, June 6th. The shares were sold at an average price of $112.05, for a total value of $10,954,792.35. Following the completion of the sale, the director owned 75,000 shares in the company, valued at $8,403,750. This trade represents a 56.59% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Elimelech Rosner sold 58,000 shares of the stock in a transaction on Friday, June 6th. The shares were sold at an average price of $112.56, for a total transaction of $6,528,480.00. Following the completion of the sale, the executive vice president owned 75,689 shares of the company's stock, valued at approximately $8,519,553.84. This represents a 43.38% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 291,744 shares of company stock worth $32,705,007 over the last quarter. 1.50% of the stock is currently owned by insiders.

HealthEquity Company Profile

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Read More

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Should You Invest $1,000 in HealthEquity Right Now?

Before you consider HealthEquity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.

While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines